Press Releases

Press Releases

CAMBRIDGE, MA – February 9, 2012 – Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today that it will apply its cutting-edge technology towards the development of an improved…
LEXINGTON, Mass., August 7, 2013 – Quanterix Corporation, delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced that the Simoa HD-1 Analyzer recently launched by Quanterix uses a “Smart Consumable” designed and manufactured by…
WASHINGTON--(BUSINESS WIRE)– April 1, 2014 The world’s leading researchers in the field of traumatic brain injury research are meeting on April 16 & 17, 2014 in Washington DC for the 4th Annual Traumatic Brain Injury Conference. Traumatic brain injuries are one of the foremost health concerns…
LEXINGTON, MA – February 13, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that their Simoa HD-1 Analyzer has been named a 2015 award finalist by the internationally…
LEXINGTON, MA – June 15, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced an alliance with PBL Assay Science (PBL), naming the Company as a Preferred Partner for assay research…
LEXINGTON, MA – October 28, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the launch of Simoa 2.0, its next-generation ultrasensitive immunoassay platform. Simoa 2.0…
February 10, 2016
Quanterix announces an alliance with Frontage Laboratories, naming the Company as a Preferred Partner for assay research and development. Leveraging Simoa’s sensitivity and revolutionary digital approach for assay development and research, Frontage will have the ability to enter new markets and…
February 3, 2017
HOUSTON and LEXINGTON, Mass.—February 3, 2017—Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced that Kevin Hrusovsky, Quanterix Chief Executive Office
July 6, 2017
Breakthrough Research Published in PLOS ONE Demonstrates Quantitative, PCR-Free Detection of MicroRNA